SMN1 and acute lymphoblastic leukemia: The NSM niche was associated with additional difficulties in achieving complete remission after therapy in ALL patients, i.e., the transit of Nestin+ MSCs to a-SMA+ CAFs might correlate with BM fibrosis and poor prognosis in ALL.